Great meeting with European Medicines Agency discussing the PRIME-ROSE and PCM4EU - Personalised Cancer Medicine for all EU citizens projects!

Visit the PCM4EU webbsite: Combining expertise across borders to promote Precision Cancer Medicine i Europe.

In episode 2 and 3, we meet Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, PhD and Pharmacist, Medicine & Society at CZ Health Insurance and Member of the National Payer’s Evaluation Committee for Specialized Medicines and Companion Diagnostics (CieBAG).

Testbed Sweden Precision Health Cancer is a national collaborative project for the design and method development of precision medicine treatment studies - for a more equal and sustainable health and cancer care where every patient and resident is offered accurate and individually tailored prevention, diagnosis, treatment, and follow-up based on their unique conditions, such as genetic profile and specific biomarkers.

PRIME-ROSE - A European precision cancer medicine trial network and implementation initiative funded by the EU Cancer Mission. The project was approved by the European Commission om April 23 2023.

EU Beating Cancer Plan and the EU Cancer Mission – collaboration for effective and equitable implementation across Europe. Stockholm January 31st 2023.

he European Commission has published an implementation roadmap and progress indicators for Europe’s Beating Cancer Plan to monitor developments on the ten flagship initiatives as well as its other actions.

Vision Zero Cancer and Genomic Medicine Sweden (GMS) join forces with SciLifeLab, public sector authorities, regions, healthcare, academia, industry and patient associations to create an innovation milieu that facilitates the introduction of more precise prevention and treatment in cancer care.